| Substance | Receptor profile | Trial | Weight change | Placebo | | --- | --- | --- | --- | --- | | Retatrutide | GIP/GLP-1/glucagon | Phase 2 (48 wk) | -8.7 to -24.2 % | -2.1 % | | Tirzepatide | GIP/GLP-1 | SURMOUNT-1 (72 wk) | -16.0 to -22.5 % | -3.1 % | | Semaglutide | GLP-1 | STEP 1 (68 wk) | -14.9 % | -2.4 % | | Cagrilintide + semaglutide | Amylin + GLP-1 | Phase 1b (20 wk) | -15.7 to -17.1 % | -9.8 %* | | CagriSema | Amylin + GLP-1 | REDEFINE 1 (68 wk) | -20.4 % | -3.0 % | *Comparator arm semaglutide alone
If all the nations participating in the BIO-5the biopharma partnership between United States, the European Union, India, Japan, and the Republic of Korea launched by the Biden White Housesourced identical intermediates from identical Indian manufacturers dependent on Chinese inputs, that coordination would only produce the semblance of diversification
Lancet (1999) 353(9167):18659
It's because appetite and portion sizes are smaller
Therefore, glucagon acts not only to increase glucose production but also to induce lipolysis, fatty acid oxidation, ketogenesis, increase thermogenesis and energy expenditure, bile acid synthesis, and finally induce satiation and reduce food intake [22, 23]
While most cases are mild and temporary, seek medical attention if diarrhea persists beyond 4 weeks or is accompanied by severe symptoms like high fever, blood in stool, or signs of severe dehydration
